Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

14

Revenue 2017

Lilly

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Lilly's 2013 sales performance.

Lilly

AbbVie’s Rinvoq has ‘marginal clinical benefit’ over Humira at increased cost, says ICER

AbbVie’s Rinvoq has ‘marginal clinical benefit’ over Humira at increased cost, says ICER tofacitinib) and Eli Lilly’s Olumiant (baricitinib).

MSD’s Keytruda scores another EU okay, in head and neck cancer

MSD’s Keytruda scores another EU okay, in head and neck cancer cancer for a decade – the EXTREME regimen of Eli Lilly’s Erbitux (cetuximab) with a platinum drug plus 5-FU – in the PD-L1-expressing group.

Karuna’s shares spike on schizophrenia drug data

Karuna’s shares spike on schizophrenia drug data KarXT combines a central nervous system-acting muscarinic agonist (Eli Lilly-developed  xanomeline) – which aims to tackle the psychosis symptoms – with a muscarinic receptor antagonist (trospium) that can’t penetrate the

Bayer, Merck’s high-risk heart failure drug comes good in phase 3

Bayer, Merck’s high-risk heart failure drug comes good in phase 3 Another question for vericiguat is how it will stack up against SGLT2 inhibitors such as Boehringer Ingelheim/Eli Lilly’s Jardiance (empagliflozin) and AstraZeneca’s Farxiga (dapagliflozin).

FDA advisors say no to empagliflozin in type 1 diabetes

FDA advisors say no to empagliflozin in type 1 diabetes Approval of Boehringer, Lilly-partnered drug expansion looks unlikely. Boehringer Ingelheim and Eli Lilly’s hopes of expanding the use of their empagliflozin drug into type 1 diabetes look out of ... That means Boehringer and Lilly now have to decide

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics